LAG3 and Parkinson disease: The integration of cell-based therapy, specifically through the transplantation of iPSC-derived dopaminergic neurons, combined with the strategic use of nanobodies, LAG3, and exosomes targeting α-syn aggregate spreading and neurotoxicity, represents a promising and ideal approach for treating PD.